GOLDMAN SACHS GROUP INC - FORMA THERAPEUTICS HLDGS INC ownership

FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 95 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q4 2021. The put-call ratio across all filers is 2.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of FORMA THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2022$6,415,000
+400.0%
321,553
+72.6%
0.00%
Q2 2022$1,283,000
-46.7%
186,342
-28.0%
0.00%
-100.0%
Q1 2022$2,406,000
-38.0%
258,736
-5.2%
0.00%0.0%
Q4 2021$3,880,000
-14.0%
272,853
+40.3%
0.00%0.0%
Q3 2021$4,511,000
+10.7%
194,545
+18.8%
0.00%0.0%
Q2 2021$4,076,000
-19.6%
163,735
-9.5%
0.00%0.0%
Q1 2021$5,068,000
+20.3%
180,886
+49.9%
0.00%0.0%
Q4 2020$4,212,000
-6.2%
120,698
+25.0%
0.00%0.0%
Q2 2020$4,491,00096,5970.00%
Other shareholders

There were no reported owners of FORMA THERAPEUTICS HLDGS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of FORMA THERAPEUTICS HLDGS INC shareholders